GTX635679 ELISA Image
SARS-CoV-2 (COVID-19) Nucleocapsid antibody [HL344]
GTX635679
Product group Antibodies
Overview
- SupplierGeneTex
- Product NameSARS-CoV-2 (COVID-19) Nucleocapsid antibody [HL344]
- Delivery Days Customer9
- CertificationResearch Use Only
- Clone IDHL344
- Concentration1 mg/ml
- IsotypeIgG
- Storage Instruction2°C to 8°C,-20°C
- UNSPSC12352203
References
- Antibody Response against SARS-CoV-2 and Seasonal Coronaviruses in Nonhospitalized COVID-19 Patients. Ruetalo N et al., 2021 Feb 24, mSphereRead more
- Development of alveolar and airway cells from human iPS cells: toward SARS-CoV-2 research and drug toxicity testing. Tsuji K et al., 2021, J Toxicol SciRead more
- Highly susceptible SARS-CoV-2 model in CAG promoter-driven hACE2-transgenic mice. Asaka MN et al., 2021 Oct 8, JCI InsightRead more
- Identification of Niemann-Pick C1 protein as a potential novel SARS-CoV-2 intracellular target. Garcia-Dorival I et al., 2021 Oct, Antiviral ResRead more
- Neuroinvasion of SARS-CoV-2 in human and mouse brain. Song E et al., 2020 Sep 8, bioRxivRead more
- Neuroinvasion of SARS-CoV-2 in human and mouse brain. Song E et al., 2021 Mar 1, J Exp MedRead more
- Pharmacological activation of STING blocks SARS-CoV-2 infection. Li M et al., 2021 May 18, Sci ImmunolRead more
- SARS-CoV-2 Bearing a Mutation at the S1/S2 Cleavage Site Exhibits Attenuated Virulence and Confers Protective Immunity. Sasaki M et al., 2021 Aug 31, mBioRead more
- SARS-CoV-2 targets neurons of 3D human brain organoids. Ramani A et al., 2020 Oct 15, EMBO JRead more
- Structure and inhibition of the SARS-CoV-2 main protease reveals strategy for developing dual inhibitors against Mpro and cathepsin L. Sacco MD et al., 2020 Jul 27, bioRxivRead more